The largest database of trusted experimental protocols

Brief Advice

Brief Advice refers to a short, focused intervention or counseling session aimed at promoting positive health behaviors or addressing specific health concerns.
These interventions are typically delivered in a single session, lasting anywhere from a few minutes to up to 30 minutes.
The goal of Brief Advice is to provide individuals with timely, targeted information and guidance to support their health and wellbeing.
This approach is often used in primary care settings, community health programs, and other healthcare contexts to encourage lifestyle changes, medication adherence, or to connect individuals with additional resources and support.
Brief Advice is designed to be concise, impactful, and easily integrated into existing clinical workflows or community-based interventions.

Most cited protocols related to «Brief Advice»

The primary aim of this two-group community-based, randomized controlled trial was to assess the efficacy of adherence-focused MI to help homeless smokers quit smoking. Once eligibility was determined, participants were randomized to either the intervention arm (NRT + MI) or to the control arm (NRT + standard care (SC)). At baseline, participants in both groups received a 2-week supply of 21-mg NRT patches [25 (link)], selected based on preferences expressed in preliminary studies [15 (link),18 (link)]. For the initial 8 weeks of the study, participants in both arms received an additional 2-week supply of nicotine patch every 2 weeks. They were instructed on how to use the patch daily; any concerns were addressed by research staff. In addition, participants randomized to the intervention arm received six MI counseling sessions, 15–20 min in length, while participants randomized to the SC arm received one brief session (10–15 min long) of advice-oriented counseling to quit smoking. The brief directive advice was designed to simulate a typical clinical encounter. The design did not include a placebo arm due to ethical concerns as well as the communal living situation of homeless people (i.e., the possibility of participants in different study arms sharing patches could lead to contamination of study groups). The primary outcome was biochemically verified smoking cessation assessed at 6 months postrandomization. Participants who did not return for the 6-month assessment were classified as treatment failures. The secondary outcome was adherence to NRT. Additional aims included identifying the potential moderating effects of substance abuse, psychiatric comorbidities, and other demographic and smoking behavior variables on intervention efficacy.
Publication 2011
Arm, Upper Brief Advice Eligibility Determination Nicotine Persons, Homeless Placebos Substance Abuse
Treatment consisted of four individual counseling sessions over three weeks with the quit date occurring at session 2, one week after session 1. Manuals are available upon request to the first author. All participants received treatment with transdermal nicotine patch with the initial dose starting at 21 mg for four weeks, followed by two weeks of 14 mg patch, and then two weeks of 7 mg patch. Standard treatment was based on recent clinical practice guidelines (Fiore et al., 2000 ) and focused on problem solving regarding high-risk situations for smoking relapse, providing support within the treatment, and encouraging participants to seek support for quitting smoking outside of treatment. Participants in ST were given brief advice to avoid or reduce drinking as much as possible while quitting smoking. In the ST-BI condition, discussion of alcohol use was reserved for the second half of sessions 1 and 2.
Sessions ranged in length from 70 minutes for session 1, 40 minutes for session 2, and 20 minutes for sessions 3 and 4. ST and ST-BI were matched on treatment contact time. In ST, 40 minutes of session 1 and 20 minutes of session 2 were dedicated to teaching progressive muscle relaxation, which has not been shown to improve smoking cessation outcomes (Fiore et al., 2000 ). Sessions 3 and 4 contained 5-minute check-ins regarding use of relaxation skills. In ST-BI, the same amount of time was dedicated to discussion of the participant’s alcohol use.
The first session of ST-BI included open-ended discussion of current drinking and smoking patterns, normative feedback on drinking level and the risk of smoking relapse associated with drinking, and preliminary goal setting. The module used the potential role of alcohol use in smoking relapse as the entry into discussion of possible short and long-term changes in drinking. Regardless of interest in long-term changes in drinking, participants were encouraged to consider abstaining from alcohol for at least two weeks after quitting smoking and preferably to abstain from drinking entirely while on nicotine patch. They also were provided recommendations for moderate drinking limits and informed of the risks associated with combined heavy drinking and smoking. The second session focused on finalizing drinking goals and supporting self-efficacy for change. A brief, 5-minute, check-in regarding achievement of drinking goals was included in sessions 3, and in session 4 recent benefits of changing drinking and longer-term drinking goals were reviewed. The alcohol module of ST-BI was conducted in the nonconfrontational therapeutic style of Motivational Interviewing (Miller & Rollnick, 2002 ), which is intended to minimize patient resistance and stresses personal responsibility for deciding to change.
Publication 2008
Alcohols Brief Advice Nicotine Transdermal Patch Patients Relapse Relaxation, Progressive Muscle Therapeutics

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2013
ARID1A protein, human Brief Advice Licensed Practical Nurse Patients Signs, Vital
ProActive is a four-year study with a complex randomised trial design [30 (link)], with central randomisation of willing participants to intervention programmes or comparison. The trial is managed from the Institute of Public Health, University of Cambridge, following MRC guidelines. Ethical approval has been obtained from the Eastern MREC, and West Suffolk, Cambridge, Huntingdon and West Essex LRECs.
The study design and patient flows (achieved at recruitment closure, October 2003, and projected to end of study) are shown in Figure 1. The focus of measurement is the adult offspring of a Type 2 diabetic parent, but the focus of the intervention programme is this individual within a family context. Participants were recruited via parents with diabetes on primary care registers (20 practices), or directly through records of their family history of diabetes (seven of the 20 practices). Sedentary individuals and their families were randomised to facilitation, either 'face-to-face' or 'distance', or to a comparison arm offering a leaflet providing brief advice on the benefits of activity. Psychological, physiological, anthropometric and biochemical data were collected at baseline and one year after randomisation, with psychological data also collected at six months after randomisation.
The study is explanatory in design, and the quality-assured intervention programmes are delivered by carefully trained and supervised family health facilitators with experience of working in primary care or the community, and backgrounds in health promotion, dietetics and nursing.
Full text: Click here
Publication 2004
Brief Advice Diabetes Mellitus Face Family Member Health Promotion Parent Patients physiology Primary Health Care
This study implemented stepped care with mandated college students at a University in the Northeast US. There were two steps of intervention. All participants received Step 1, a Brief Advice session. Mandated students reporting continued risky alcohol use 6 weeks later were randomized to (a) Step 2, a 60- minute BMI or (b) an assessment only control condition (AO). Participants then completed 3, 6 and 9 month follow-ups via web assessment.
Publication 2012
Brief Advice Student

Most recents protocols related to «Brief Advice»

The inclusion criteria for patients to be enrolled in the SBIR intervention were: a) patients aged 18 or older; b) resident of Alberta; c) cognitively and emotionally able to participate as assessed by the healthcare provider; and d) patients’ willingness to participate. Clinical providers were asked to routinely screen eligible patients for these four modifiable risk factors using standardized screening questions (Screening) [24 (link), 26 (link)–31 (link)] and discuss the screening results with the patients. Patients who screened low risk on these factors were provided positive reinforcement. Patients who screened medium or high risk on these factors were offered brief, tailored advice and resources to encourage health behavior modification (Brief Intervention). Lastly, providers were required to offer referral(s) to health promotion programs (e.g., the AlbertaQuits smoking cessation program) in the community or within the hospital for high-risk patients (or upon patient request) who could benefit from more intensive behavior change support outside the scope of brief intervention (Referral). Paper-based SBIR pathways and form were designed to guide providers in the implementation process and the documentation of screening, brief intervention, referral aspects of the intervention received by each patient (Figure 1; Supplementary Material). Not all eligible patients cared for in the participating units were invited by healthcare providers to participate in the intervention. The providers were given latitude to suspend implementation periodically based on their judgement of feasibility within their clinical workflow.
Full text: Click here
Publication 2023
Behavior Therapy Brief Advice Brief Interventions Health Personnel Patients Positive Reinforcement Wellness Programs
For those patients who participated in screening for four risk factors at baseline (i.e., SBIR intervention phase), data on screening results (or risk stratification) and brief advice and referral support received status were collected using the SBIR form. At follow-up, CATI was conducted with the patients who received SBIR intervention, upon their consent, to measure the acceptability and effectiveness of SBIR. The interviews were conducted using structured questionnaires administered by the Alberta Health Services Cancer Epidemiology and Prevention Research Team, who were contracted by the HPHS innovation team to conduct the follow-up interviews. For those who did not respond to the first call, up to 6 additional calls were made, twice per day in weekdays and up to 3 messages to call back were left. Of the 543 patients screened, 307 agreed to participate and we were able to complete follow-up interviews with 108 patients (study participants, n = 108) (Figure 2). The median time from baseline to follow-up interview was 16 weeks (interquartile range = 12 weeks, 21 weeks). The reasons for non-participation at follow-up were: a) the follow-up calls were made during the office days/hours only, which limited the response from those who did not want to pick up the phone during that time; b) follow-up calls were put on hold during the early stages of the COVID-19 pandemic as research team members were deployed to respond to the pandemic; and c) in some cases incorrect or out-of-service phone numbers had been recorded on the study form. Additionally, a considerable number of patients did not agree to be interviewed during the calls, particularly after the start of the COVID-19 pandemic.
The study variables were [1 (link)]: patients’ acceptability of being asked, in the context of their hospital visit, about their health behaviors in relation to the risk factors, and [2 (link)] the effectiveness of the SBIR intervention in terms of (a) whether patients recalled the risk factor conversation with healthcare providers; (b) whether they perceived improvement in their knowledge of the link between the risk factors and chronic disease; and (c) patient behavior change in relation to the risk factor(s). To collect the data on acceptability, patients were asked “were you ok with being asked about whether you were a tobacco user at the hospital/clinic?” The same question was asked in relation to the other three risk factors.
SBIR effectiveness was measured by asking whether the patient (a) recalled having a conversation with the healthcare provider regarding the risk factors; (b) perceived that their knowledge of the link between the risk factors and chronic disease improved after they received the SBIR intervention. During the follow-up call, patients were also ask about their current behaviors on the risk factors and whether they had made any changes in their behavior on the risk factors since they had received the SBIR intervention in hospital. Patients’ behavior change in relation to the risk factors (i.e., reduced risk-level) in the time since they received SBIR intervention was identified based on changes between their baseline screening results during the SBIR intervention and the follow-up assessment on the risk factors. That included quitting tobacco use at least for the past 30 days, reducing the levels of alcohol use to low risk (risk score of ≤3 for women or ≤4 for men on the AUDIT-C screening tool); increasing physical activity levels to adequate levels (≥150 min of moderate-strenuous physical activity in a week); increasing vegetable and fruit consumption to sufficient levels (i.e., ≥5 servings of vegetable and fruit intake per day).
Full text: Click here
Publication 2023
Brief Advice COVID 19 Disease, Chronic Fruit Health Personnel Health Risk Assessment Malignant Neoplasms Pandemics Patients Tobacco Products Vegetables Woman
Using data from the SBIR form, we calculated the proportion of patients who screened medium or high risk on modifiable risk factors; who screened medium or high risk on modifiable risk factors, the proportion of total patients at medium or high risk who received brief advice, and the proportion of patients found to be high risk at screening who then received referral support. The sociodemographic characteristics of study participants, such as age, gender, and education status, which were collected at follow-up, were analyzed using descriptive statistics as appropriate to the data type (mean and standard deviation for continuous data; frequency and proportion for categorical data).
The proportion (and 95% confidence intervals (CI)) of the study participants who either agreed or strongly agreed that they were “ok with being asked,” during their hospital visit, about their behavior with respect to the risk factors was estimated to assess the acceptability outcome. The data collected on the various effectiveness outcomes were analyzed: the proportion (95% CI) of study participants were calculated for each effectiveness outcome. A chi-squared test was used to assess whether the proportion of participants with medium or high risk on at least one risk factor was statistically different (α < 0.05) between the baseline and the follow-up. Data were analyzed using SPSS version 25.0.
Full text: Click here
Publication 2023
Brief Advice Gender Patients
We analyzed the archived data from our previously published randomized controlled trial of a brief self-determination theory-based smoking cessation intervention adopted for smokers recruited from emergency departments [11 (link)]. Ethical approval was obtained from the Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster (UW14-528). The trial protocol has been published elsewhere [11 (link)]. Participants provided written informed consent.
Participants who presented at the emergency departments of four major acute care hospitals in different districts of Hong Kong were considered eligible if they were current smokers (occasional or daily) aged 18 years or older and triaged as either semi-urgent (level 4) or non-urgent (level 5) [12 ]. Exclusion criteria included an impaired mental status, cognitive impairment, communication barriers, or enrollment in other smoking cessation projects.
The sample size was calculated according to a previous trial [3 (link)] of a smoking reduction plus nicotine replacement therapy intervention involving 1154 Chinese adult smokers unwilling to quit smoking (biochemically validated quit rate of 4.4% [10 of 226] in the control group and 8.0% [74 of 928] in the intervention group at 6months). To detect a two-sided significant difference between groups by a chi-square test for comparing proportions with a power of 80% and significance level of 5%, the required sample size was estimated to be 1088 participants (544 in each group). Given an expected attrition rate of approximately 30% at the 6-month follow-up, the target was at least 1554 individuals (777 in each group). Between July 4, 2015 and March 17, 2017, 1571 smokers who presented at 4 major emergency departments consented to participate in this randomized controlled trial and were randomized into an intervention group (n = 787) and a control group (n = 784). Participants in the intervention group received brief advice and were given the option to either quit immediately (QI) or progressively (QP). Participants in the control group received a smoking cessation leaflet. Other details of the trial have been reported elsewhere [11 (link)]. Table 1 shows the characteristics of participants in the QI, QP, and the control groups. A Consolidated Standards of Reporting Trials (CONSORT) flowchart is presented in Fig 1.
Full text: Click here
Publication 2023
Adult Brief Advice Chinese Disorders, Cognitive Ethics Committees, Research Nicotine Surgical Replantation Therapeutics Therapy, Hormone Replacement Tooth Attrition
The intervention is designed to support patients with CNCP to taper and reduce their opioid use, promoting increased self-management of pain. The goal is harm reduction where cessation is not possible, and the pilot will be aimed at reducing opioid use to within safe levels. Harm reduction refers to general opioid use and potential harms for participating in the study. The intervention is underpinned by psychological theory59–61 (link) and delivered using validated behaviour change techniques.62 (link) The intervention will be delivered by trained specialists (pharmacists/nurse prescribers) during an appointment and comprises a structured dose reduction prescribing protocol for opioids, education about harms, including worsening pain, withdrawal symptoms, decreased tolerance and risk of overdose and overdose death from both prescribed and over the counter medications if used inappropriately, alongside brief advice supported by written and online materials. During the face-to-face sessions, AHPs will offer emotional, informational and instrumental support to help patients self-manage their pain without opioids. The materials will be available on a range of media, with participants having access to video-based online media throughout the study. The study will also capitalise on and promote existing social prescribing mechanisms that are in place within Knowsley Place to further support patients’ self-management. A dedicated website has been set up (hosted by LJMU), which collates existing widely and freely available online resources for pain education and management.
Publication 2023
Behavior Therapy Brief Advice Drug Overdose Drugs, Non-Prescription Drug Tapering Emotions Face Harm Reduction Immune Tolerance Management, Pain Nurses Opioids Pain Patients Self-Management Specialists Withdrawal Symptoms

Top products related to «Brief Advice»

Sourced in United States, Austria, United Kingdom, Cameroon, Belgium, Israel, Japan, Australia, France, Germany
SAS v9.4 is a software product developed by SAS Institute. It is a comprehensive data analysis and statistical software suite. The core function of SAS v9.4 is to provide users with tools for data management, analysis, and reporting.

More about "Brief Advice"

Brief Advice, also known as Brief Intervention or Brief Counseling, refers to a concise, focused approach to promoting positive health behaviors and addressing specific health concerns.
These short sessions, typically ranging from a few minutes to up to 30 minutes, aim to provide individuals with timely, targeted information and guidance to support their overall wellbeing.
This evidence-based technique is commonly utilized in primary care settings, community health programs, and other healthcare contexts.
The goal of Brief Advice is to encourage lifestyle changes, medication adherence, or to connect individuals with additional resources and support, all within an easily integrated clinical workflow or community-based intervention.
Brief Advice draws on the principles of motivational interviewing and behavior change theories to deliver impactful, personalized guidance.
This approach has been shown to be effective in addressing a variety of health issues, from promoting smoking cessation to improving medication compliance and supporting weight management.
In the context of SAS v9.4, Brief Advice aligns with the software's capabilities in data analysis, reporting, and visualization.
By leveraging SAS's robust statistical tools and data management features, healthcare professionals can deliver tailored Brief Advice interventions based on comprehensive patient data, ultimately enhancing the effectiveness of these targeted health interventions.